Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942604 · ClinicalTrials.gov registry record · Phase 3
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
A Phase 3 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 3
- Development phase
- 203
- Enrollment target
NCT00942604: Completed Phase 3 study, sponsored by Peplin.
NCT00942604 is a Phase 3 study that has completed, run by Peplin. The registered enrollment target is 203 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00942604, a Phase 3 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Primary Outcome
Proportion of Patients with Complete Clearance of the treatment field defined as no clinically visible Actinic Keratoses (AK) lesions in the selected treatment area
Interventions
- DRUG Vehicle gel
- DRUG PEP005 (ingenol mebutate) Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
What the finished NCT00942604 record still lists
NCT00942604 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle gel is the first listed.
NCT00942604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00942604 about?
NCT00942604 is a clinical study titled "A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations". The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
What is the current status of trial NCT00942604?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 203 participants. The study started on 2009-07. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00942604?
The interventions under investigation include: Vehicle gel (DRUG), PEP005 (ingenol mebutate) Gel (DRUG).
Who is sponsoring clinical trial NCT00942604?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00942604's enrollment target sits among peer trials
203 1352nd of 2000 higher than 648 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia